Loading...

PE anti-mouse IFN-γ Antibody PE anti-mouse IFN-γ Antibody

Pricing & Availability
Clone
XMG1.2 (See other available formats)
Regulatory Status
RUO
Other Names
Interferon-γ, Immune interferon, Type II interferon, T cell interferon, Macrophage-activating factor (MAF)
Isotype
Rat IgG1, κ
Ave. Rating
Submit a Review
Product Citations
publications
XMG1.2
PMA/Ionomycin-stimulated BALB/c T-cells were stained with CD3 FITC and XMG1.2 PE
  • XMG1.2
    PMA/Ionomycin-stimulated BALB/c T-cells were stained with CD3 FITC and XMG1.2 PE
Compare all formats See PE spectral data
Cat # Size Price Quantity Check Availability Save
505807 25 µg NOK322
Check Availability


Need larger quantities of this item?
Request Bulk Quote
505808 100 µg NOK908
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

IFN-γ is a potent multifunctional cytokine which is secreted primarily by activated NK cells and T cells. Originally characterized based on anti-viral activities, IFN-γ also exerts anti-proliferative, immunoregulatory, and proinflammatory activities. IFN-γ can upregulate MHC class I and II antigen expression by antigen-presenting cells.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
E. coli-expressed, recombinant mouse IFN-γ
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The IFN-γ antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

ICFC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by intracellular immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤0.25 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

ELISA1-4,11,14 or ELISPOT5 Detection: The biotinylated XMG1.2 antibody is useful as a detection antibody for a sandwich ELISA or ELISPOT assay, when used in conjunction with purified R4-6A2 antibody (Cat. No. 505702/505706) as the capture antibody and recombinant mouse IFN-γ (Cat. No. 575309) as the standard.
ELISA or ELISPOT Capture: The purified XMG1.2 antibody is useful as a capture antibody for a sandwich ELISA or ELISPOT assay, when used in conjunction with biotinylated R4-6A2 antibody (Cat. No. 505704) as the detection antibody and recombinant mouse IFN-γ (Cat. No. 575309) as the standard. The LEAF™ purified antibody is suggested for ELISPOT capture (Cat. No. 505812).
Flow Cytometry7,8,12,13,16: The fluorochrome-labeled XMG1.2 antibody is useful for intracellular immunofluorescent staining and flow cytometric analysis to identify IFN-γ-producing cells within mixed cell populations.
Neutralization1-3,9,10: The XMG1.2 antibody can neutralize the bioactivity of natural or recombinant IFN-γ. The LEAF™ purified antibody (Endotoxin <0.1 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for neutralization of mouse IFN-γ bioactivity in vivo and in vitro (Cat. No. 505812). For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Cat. No. 505834) with a lower endotoxin limit than standard LEAF™ purified antibodies (Endotoxin <0.01 EU/µg).
Additional reported applications (for the relevant formats) include: Western blotting, immunohistochemical staining of frozen tissue sections6,22,23, and immunocytochemistry.
Note: For testing mouse IFN-γ in serum, plasma or supernatant, BioLegend's ELISA Max™ Sets (Cat. No. 430801 to 430806) are specially developed and recommended.

Application References
  1. Abrams J, et al. 1992. Immunol. Rev. 127:5. (ELISA, Neut)
  2. Sander B, et al. 1993. J. Immunol. Meth. 166:201. (ELISA, Neut)
  3. Abrams J, et al. 1995. Curr. Prot. Immunol. John Wiley and Sons, New York. Unit 6.20. (ELISA, Neut)
  4. Yang X, et al. 1993. J. Immunoassay 14:129. (ELISA)
  5. Klinman D, et al. 1994. Curr. Prot. Immunol. John Wiley and Sons, New York. Unit 6.19. (ELISPOT)
  6. Sander B, et al. 1991. Immunol. Rev. 119:65. (IHC)
  7. Ferrick D, et al. 1995. Nature 373:255. (FC)
  8. Ko SY, et al. 2005. J. Immunol. 175:3309. (FC) PubMed
  9. Peterson KE, et al. 2000. J. Virol. 74:5363. (Neut)
  10. DeKrey GK, et al. 1998. Infect. Immun. 66:827. (Neut)
  11. Dzhagalov I, et al. 2007. J. Immunol. 178:2113. (ELISA)
  12. Lawson BR, et al. 2007. J. Immunol. 178:5366. (FC)
  13. Lee JW, et al. 2006. Nature Immunol. 8:181. (FC) PubMed
  14. Xu G, et al. 2007. J. Immunol. 179:5358. (ELISA) PubMed
  15. Montfort M, et al.2004. J. Immunol. 173:4084. PubMed
  16. Haring JS, et al. 2008. J. Immunol. 180:2855. (FC) PubMed
  17. Jordan JM, et al. 2008. Infect Immun. 76:3717. PubMed
  18. Tonkin DR, et al. 2008. J. Immunol. 181:4516. PubMed
  19. Charles N, et al. 2010. Nat. Med. 16:701. (FC) PubMed
  20. Cui Y, et al. 2009. Invest. Ophth. Vis. Sci. 50:5811. (FC) PubMed
  21. Mykkanen OT, et al. 2014. PLoS One. 9:114790. PubMed
  22. Yokogawa M, et al. 2013. Mol. Carcinog. 52:760. (IHC)
  23. Mottram PL, et al. 1998. J Immunol. 161:602. (IHC)
Product Citations
  1. Bradley CP et al. 2017. Cell host & microbe. 22(5):697-704 . PubMed
  2. Wu J et al. 2017. Immunity. 47(6):1114-1128 . PubMed
  3. Toubai T, et al. 2017. Blood Adv. 1.095138889. PubMed
  4. Yu X, et al. 2020. Nat Commun. 11:1110. PubMed
  5. Wang H, et al. 2013. J Immunol. 191:6010. PubMed
  6. Kim K, et al. 2016. PLoS One. 11: 0148576. PubMed
  7. Liu Y, et al. 2021. Cell Metabolism. 33(6):1221-1233.e11. PubMed
  8. Chen Y, et al. 2020. Virol Sin. . PubMed
  9. Sandu I, et al. 2020. Nat Commun. 11:4454. PubMed
  10. Wang HH, et al. 2022. J Biomed Sci. 29:36. PubMed
  11. Miki H, et al. 2020. J Immunol. 204:1892. PubMed
  12. Zhang H, et al. 2022. Eur J Immunol. 52:978. PubMed
  13. Jia JJ, et al. 2022. J Leukoc Biol. 112:157. PubMed
  14. Chakraborty P, et al. 2022. Cancer Res. 82:1969. PubMed
  15. Lu R, et al. 2022. Scand J Immunol. 96:e13177. PubMed
  16. Tu J, et al. 2022. Cancer Sci. 113:2496. PubMed
  17. Liu H, et al. 2022. Cell Rep Med. 3:100660. PubMed
  18. Backlund C, et al. 2022. Proc Natl Acad Sci U S A. 119:e2204078119. PubMed
  19. Kang IH, et al. 2022. iScience. 25:104818. PubMed
  20. Wei M, et al. 2022. Front Immunol. 13:1017574. PubMed
  21. Xu H, et al. 2022. Aging Dis. 13:1875. PubMed
  22. Tan TCJ, et al. 2022. Nat Commun. 13:7796. PubMed
  23. Wang Z, et al. 2022. Cell Rep. 41:111890. PubMed
  24. Chan L, et al. 2022. Cells. 12: . PubMed
  25. Liu H, et al. 2023. Cell Death Differ. :. PubMed
  26. Mandour MF, et al. 2023. Front Med (Lausanne). 9:1057252. PubMed
  27. Kuehm LM, et al. 2021. Cancer Immunol Res. 9:227. PubMed
  28. Khojandi N, et al. 2021. Cancer Immunol Res. 9:214. PubMed
  29. Wight AE, et al. 2022. Proc Natl Acad Sci U S A. 119:e2200757119. PubMed
  30. Wu MJ, et al. 2022. Cancer Discov. 12:812. PubMed
  31. Tan L, et al. 2022. Aging Dis. 13:1562. PubMed
  32. Chen R, et al. 2022. J Mol Cell Biol. 14:. PubMed
  33. Cheng C, et al. 2022. Cell Mol Gastroenterol Hepatol. 15:261. PubMed
  34. Pan Y, et al. 2023. Adv Sci (Weinh). 10:e2206792. PubMed
  35. Wang X, et al. 2023. J Immunother Cancer. 11:. PubMed
  36. Lu C, et al. 2023. Antiviral Res. 212:105556. PubMed
  37. Zhuang WR, et al. 2023. Nat Commun. 14:1675. PubMed
  38. Tan X, et al. 2023. Adv Sci (Weinh). 10:e2206768. PubMed
  39. Martins Nascentes Melo L, et al. 2023. J Immunother Cancer. 11:. PubMed
  40. Li D, et al. 2023. Ann Med. 55:2189295. PubMed
  41. Zuo B, et al. 2023. Clin Transl Oncol. . PubMed
  42. Pandit M, et al. 2023. Nat Commun. 14:2593. PubMed
  43. Yu L, et al. 2023. Front Oncol. 13:1174713. PubMed
  44. Deng G, et al. 2023. Cancers (Basel). 15:. PubMed
  45. Wang Y, et al. 2023. iScience. 26:106630. PubMed
  46. Gao Y, et al. 2023. iScience. 26:106729. PubMed
  47. Vereertbrugghen A, et al. 2023. J Neuroinflammation. 20:120. PubMed
  48. Changsheng H, et al. 2023. Sci Adv. 9:eade4186. PubMed
  49. Yang QC, et al. 2023. iScience. 26:106916. PubMed
  50. Lin W, et al. 2020. Theranostics. 10:4871. PubMed
  51. Zhou J, et al. 2019. Immunity. 50:403. PubMed
  52. Shi L, et al. 2019. Theranostics. 9:4115. PubMed
  53. Alissafi T, et al. 2018. J Clin Invest. 128:3840. PubMed
  54. Gern BH, et al. 2021. Cell Host Microbe. 29(4):594-606.e6. PubMed
  55. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  56. Zhou J, et al. 2021. Int J Med Sci. 18:3516. PubMed
  57. Kim D, et al. 2021. Nanomicro Lett. 13:31. PubMed
  58. Gálvez-Cancino F, et al. 2017. Vaccine. 10.1016/j.vaccine.2017.06.041. PubMed
  59. Wang X, et al. 2018. Int Immunopharmacol. 56:249. PubMed
  60. Liu QZ, et al. 2018. Front Immunol. 1.131944444. PubMed
  61. Xia S, et al. 2014. J Leukoc Biol. 95:733. PubMed
  62. Su N, Xiong Y 2016. Sci Rep. 6:22658. PubMed
  63. Dong L, et al. 2021. Cancer Cell. . PubMed
  64. Yang F, et al. 2021. Front Microbiol. 11:512581. PubMed
  65. Kiritsy MC, et al. 2021. Elife. 10:. PubMed
  66. Stegelmeier AA, et al. 2022. Biomedicines. 10:. PubMed
  67. Chen L, et al. 2022. Mol Ther Oncolytics. 24:522. PubMed
  68. Liang S, et al. 2022. Acta Pharm Sin B. 12:2494. PubMed
  69. Coleby R, et al. 2021. Clin Exp Rheumatol. :39. PubMed
  70. Zhang S, et al. 2022. Cell Death Dis. 13:844. PubMed
  71. Chakrabarti J, et al. 2018. Oncotarget. 9:37439. PubMed
  72. Oyarce C, et al. 2018. Front Immunol. 8:1794. PubMed
  73. Tang Y, et al. 2020. Front Immunol. 11:585918. PubMed
  74. Mayer RL, et al. 2022. Nat Commun. 13:6075. PubMed
  75. Snyder LM, et al. 2021. PLoS Pathog. 17:e1009970. PubMed
  76. Nagatake T, et al. 2022. Mucosal Immunol. 15:289. PubMed
  77. Herman JD, et al. 2021. Nat Commun. 12:6853. PubMed
  78. Galeano Niño JL, et al. 2020. J Cell Sci. . PubMed
  79. Saito S, et al. 2020. Nutrients. 12:. PubMed
  80. Chen D, et al. 2018. Nat Commun. 9:873. PubMed
  81. Koenecke C, et al. 2012. J Immunol. 189:2890. PubMed
  82. Michel M, et al. 2012. Proc Natl Acad Sci U S A. 109:17459. PubMed
  83. Wang Y, et al. 2016. Sci Rep. 6:31881. PubMed
  84. Papafragkos I, et al. 2022. Front Immunol. 13:889075. PubMed
  85. Xiong A, et al. 2022. EBioMedicine. 83:104239. PubMed
  86. Pan W et al. 2017. Immunity. 47(2):284-297 . PubMed
  87. Ning X, et al. 2019. Mol Cell. 74:19. PubMed
  88. Uchimura T et al. 2018. Immunity. 49(6):1049-1061 . PubMed
  89. Lv H, et al. 2020. Cell Metabolism. 33(1):110-127.e5. PubMed
  90. Alissafi T, et al. 2020. Cell Metabolism. 32(4):591-604.e7. PubMed
  91. Sharma S, et al. 2015. J Immunol. 194:5529. PubMed
  92. Dai B, et al. 2022. Theranostics. 12:7603. PubMed
  93. Kuttke M, et al. 2022. Front Immunol. 13:695576. PubMed
  94. Xu X, et al. 2021. J Nanobiotechnology. 19:376. PubMed
  95. Subbiah J, et al. 2022. NPJ Vaccines. 7:68. PubMed
  96. Wang C, et al. 2021. Cell Rep. 37:110021. PubMed
  97. Uchil PD et al. 2018. Cell host & microbe. 25(1):87-100 . PubMed
  98. Probst P, et al. 2017. Cancer Res. 77:3644. PubMed
  99. Caronni N, et al. 2018. Cancer Res. 78:1685. PubMed
  100. Wan Y, et al. 2014. Vaccine. 41:241. PubMed
  101. Sandrock I, et al. 2015. PLoS One. 10: 0145010. PubMed
  102. Koren N, et al. 2021. Cell Host Microbe. 29(2):197-209.e5. PubMed
  103. An J, et al. 2022. iScience. 25:103570. PubMed
  104. Han JP, et al. 2022. Sci Adv. 8:eabj6901. PubMed
  105. Yu Y, et al. 2022. Nat Commun. 13:6357. PubMed
  106. Hegde S, et al. 2020. Cancer Cell. 37(3):289-307. PubMed
  107. Shami A, et al. 2015. Sci Rep. 5: 13904. PubMed
  108. Gungor B, et al. 2014. Sci Transl Med. 6:235. PubMed
  109. Srey MT, et al. 2020. PLoS Negl Trop Dis. 14:e0008842. PubMed
  110. Chen D, et al. 2022. J Neuroinflammation. 19:112. PubMed
  111. Cha SE, et al. 2021. Oncoimmunology. 10:1899469. PubMed
  112. Canton J, et al. 2021. Nat Immunol. 22:140. PubMed
  113. Espinosa JR, et al. 2018. Front Immunol. 9:1371. PubMed
  114. Hundt M, et al. 2009. J Immunol. 183:1685. PubMed
  115. Cho K, Hill A 2008. J Immunol Methods. 330:137. PubMed
  116. Condotta S, et al. 2015. J Immunol. 195: 116 - 125. PubMed
  117. Satoh M, et al. 2016. Sci Rep. 6:28473. PubMed
  118. Gong Y, et al. 2020. Cell Metabolism. 33(1):51-64.e9. PubMed
  119. Duan RN, et al. 2021. J Neuroinflammation. 18:145. PubMed
  120. Hanasoge Somasundara AV, et al. 2021. Cell Rep. 37:110099. PubMed
  121. Cheng B, et al. 2022. Cancer Commun (Lond). 42:17. PubMed
  122. Mirando AC, et al. 2020. Oncoimmunology. 9:1760685. PubMed
  123. Garo LP, et al. 2019. Cell Rep. 28:3353. PubMed
  124. Li W, et al. 2019. Nat Commun. 10:3349. PubMed
  125. Yan Y, et al. 2018. JCI Insight. 3. PubMed
  126. Place D, et al. 2017. PLoS One. 10.1371/journal.pone.0190384. PubMed
  127. Palazon A, et al. 2017. Cancer Cell. . 10.1016/j.ccell.2017.10.003. PubMed
  128. Brigas HC, et al. 2021. Cell Reports. 36(9):109574. PubMed
  129. Sartorius R, et al. 2015. EMBO Mol Med. 7: 973 - 988. PubMed
  130. Reese B, et al. 2020. J Immunol. 205:3218. PubMed
  131. Marcus A et al. 2018. Immunity. 49(4):754-763 . PubMed
  132. Ma Y, et al. 2013. J Immunol. 190:5588. PubMed
  133. Dutow P, et al. 2014. J Infect Dis. 209:1269. PubMed
  134. QT N, et al. 2015. Antimicrob Agents Chemother. 59: 6308-6316. PubMed
  135. Latasa C, et al. 2016. PLoS One. 11: 0161216. PubMed
  136. Holokai L, et al. 2020. Cancers (Basel). 12:00. PubMed
  137. Galeano Niño JL, et al. 2020. J Cell Sci. 133:00:00. PubMed
  138. Vaena S, et al. 2021. Cell Reports. 35(5):109076. PubMed
  139. Bosnjak B, et al. 2021. Front Immunol. 12:772240. PubMed
  140. Tian X, et al. 2022. J Cell Mol Med. 26:693. PubMed
  141. Kraus Z, et al. 2008. J Immunol. 181:7800. PubMed
  142. Lin W, et al. 2019. EBioMedicine. 49:133. PubMed
  143. Leclerc M, et al. 2019. Nat Commun. 10:3345. PubMed
  144. Nagatake T, et al. 2018. Int Immunol. 30:471. PubMed
  145. Chatterjee S et al. 2017. Cell metabolism. 27(1):85-100 . PubMed
  146. Yan J, et al. 2020. Cell Rep. 107820:31. PubMed
  147. Shen JZ, et al. 2020. Cell. 184(2):352-369.e23. PubMed
  148. Ren Y, et al. 2015. Sci Rep. 5: 18099. PubMed
  149. Yang Z, et al. 2021. Onco Targets Ther. 14:4239. PubMed
  150. De Ponte Conti B, et al. 2021. Elife. 10:. PubMed
  151. Tanaka Y, et al. 2020. Sci Rep. 10:17284. PubMed
  152. Ohtsuka J, et al. 2021. iScience. Online ahead of print. PubMed
  153. Lu J, et al. 2021. Cell Death Discov. 7:165. PubMed
  154. Karandikar SH, et al. 2019. JCI Insight. 5. PubMed
  155. Bartolacci C, et al. 2018. Cancer Immunol Res. 1.281944444. PubMed
  156. Montfort M, et al. 2004. J Immunol. 173:4084. PubMed
  157. Koelwyn GJ, et al. 2020. Nat Med. 1452:26. PubMed
  158. Xu P, et al. 2020. Cancer Immunol Res. 8:1193. PubMed
  159. Xu Q, et al. 2021. Theranostics. 11:1937. PubMed
  160. Guo S, et al. 2021. Sci Rep. 11:23745. PubMed
  161. Kalafati L, et al. 2020. Cell. 183:771. PubMed
  162. Roy S, et al. 2019. Front Immunol. 2.404166667. PubMed
  163. Yuan X, et al. 2017. Elife. 6:e29540. PubMed
  164. Nagatake T, et al. 2018. J Allergy Clin Immunol. 142:470. PubMed
  165. Zhang J, et al. 2018. Nature. 553:91. PubMed
  166. Wang Y, et al. 2020. Virol Sin. 36:122. PubMed
  167. Hirata SI, et al. 2020. Allergy. 75:1939. PubMed
  168. Castiglioni P, et al. 2017. PLoS Negl Trop Dis. 10.1371/journal.pntd.0005240. PubMed
  169. Dong M, et al. 2022. J Immunother Cancer. 10:. PubMed
  170. Ye Q, et al. 2022. NPJ Vaccines. 7:84. PubMed
  171. Stephens WZ, et al. 2021. Cell Rep. 37:109916. PubMed
  172. Raju S, et al. 2020. Cell Reports. 29(9):2556-2564.e3.. PubMed
  173. Mandour MF, et al. 2020. Infect Agent Cancer. 15:30. PubMed
  174. Miura N, et al. 2017. Mol Ther. 10.1016/j.ymthe.2017.01.020. PubMed
  175. Miao W, et al. 2020. J Immunol. 1486:204. PubMed
  176. Cartwright ANR, et al. 2021. Cancer Immunol Res. 9:470. PubMed
  177. Li H, et al. 2021. Front Immunol. 12:739605. PubMed
  178. Kiritsy MC, et al. 2021. Elife. 10:. PubMed
  179. Tian D, et al. 2019. Nat Commun. 10:4246. PubMed
  180. Mah-Som AY, et al. 2021. Cell Reports. 35(9):109209. PubMed
  181. Lee J, et al. 2007. Nat Immunol. 8:181. PubMed
  182. Ma Q, et al. 2022. Vaccines (Basel). 10:. PubMed
  183. Kim MY, et al. 2022. Nat Commun. 13:3296. PubMed
  184. Johnson RM, et al. 2021. Front Immunol. 11:614697. PubMed
  185. Ding L et al. 2018. Cell reports. 25(11):2972-2980 . PubMed
  186. Tomaru U et al. 2019. Cell reports. 26(3):639-651 . PubMed
  187. Hoechst B, et al. 2016. J Immunol. 195:1517-1523. PubMed
  188. Molgora M, et al. 2020. Cell. 182:886. PubMed
  189. Fang W, et al. 2021. J Exp Clin Cancer Res. 40:4. PubMed
  190. Chen L, et al. 2021. Theranostics. 11:6668. PubMed
  191. Rousso-Noori L, et al. 2021. Nat Commun. 12:3615. PubMed
  192. Wang Y, et al. 2021. Front Immunol. 11:601601. PubMed
  193. Prakash MD, et al. 2021. PLoS One. 16:e0247492. PubMed
  194. Zhang X, et al. 2020. J Cancer. 11:648. PubMed
  195. Chakraborty P, et al. 2020. Cell Reports. 28(7):1879-1893.e7.. PubMed
  196. Zhao K, et al. 2021. Biomed Res Int. 7619849:2020. PubMed
  197. Charlton J, et al. 2015. PLoS One. 10:119200. PubMed
  198. Nakao R, et al. 2022. NPJ Vaccines. 7:153. PubMed
  199. McAusland TM, et al. 2021. Mol Ther Oncolytics. 20:306. PubMed
  200. Li H, et al. 2022. iScience. 25:104481. PubMed
  201. Schmit T, et al. 2022. Cell Rep. 38:110456. PubMed
  202. Zhang X, et al. 2021. Front Pharmacol. 12:706748. PubMed
  203. Liu X, et al. 2021. Adv Sci (Weinh). 8:e2100233. PubMed
  204. Timilshina M, et al. 2020. Cell Reports. 27(10):2948-2961.e7.. PubMed
  205. Kim YS, et al. 2018. Front Immunol. 9:1093. PubMed
  206. Wang N, et al. 2020. Front Immunol. 1.765972222. PubMed
  207. Gaylo A, et al. 2013. Transpl Immunol. 20:163. PubMed
  208. Dourcy M, et al. 2020. Mucosal Immunol. 13:799. PubMed
  209. Kerdidani D, et al. 2022. J Exp Med. 219:. PubMed
  210. Zheng Y, et al. 2022. Transl Res. :. PubMed
  211. Brenner E, et al. 2020. Nat Commun. 11:1335. PubMed
  212. Qi S, et al. 2020. Theranostics. 10:1814. PubMed
  213. Chen S, et al. 2018. Nat Commun. 9:5298. PubMed
  214. Bing Wu et al. 2018. Immunity. 49(5):886-898 . PubMed
  215. Nabekura T, et al. 2020. Immunity. 96:52. PubMed
  216. Chow AK, et al. 2021. Cellular and Molecular Gastroenterology and Hepatology. :. PubMed
  217. Tripathi D, et al. 2016. Nat Commun. 7:13896. PubMed
  218. Chen PM, et al. 2022. Sci Adv. 8:eabo4271. PubMed
  219. Song X, et al. 2022. Transl Oncol. 15:101306. PubMed
  220. Yang F, et al. 2021. Nat Commun. 12:3424. PubMed
  221. Li X, et al. 2021. Front Cell Dev Biol. 9:647713. PubMed
  222. Bradley CP et al. 2017. Cell host & microbe. 22(5):697-704 . PubMed
  223. Wu J et al. 2017. Immunity. 47(6):1114-1128 . PubMed
  224. Toubai T, et al. 2017. Blood Adv. 1.095138889. PubMed
  225. Yu X, et al. 2020. Nat Commun. 11:1110. PubMed
  226. Wang H, et al. 2013. J Immunol. 191:6010. PubMed
  227. Kim K, et al. 2016. PLoS One. 11: 0148576. PubMed
  228. Liu Y, et al. 2021. Cell Metabolism. 33(6):1221-1233.e11. PubMed
  229. Chen Y, et al. 2020. Virol Sin. . PubMed
  230. Sandu I, et al. 2020. Nat Commun. 11:4454. PubMed
  231. Wang HH, et al. 2022. J Biomed Sci. 29:36. PubMed
  232. Miki H, et al. 2020. J Immunol. 204:1892. PubMed
  233. Zhang H, et al. 2022. Eur J Immunol. 52:978. PubMed
  234. Jia JJ, et al. 2022. J Leukoc Biol. 112:157. PubMed
  235. Chakraborty P, et al. 2022. Cancer Res. 82:1969. PubMed
  236. Lu R, et al. 2022. Scand J Immunol. 96:e13177. PubMed
  237. Tu J, et al. 2022. Cancer Sci. 113:2496. PubMed
  238. Liu H, et al. 2022. Cell Rep Med. 3:100660. PubMed
  239. Backlund C, et al. 2022. Proc Natl Acad Sci U S A. 119:e2204078119. PubMed
  240. Kang IH, et al. 2022. iScience. 25:104818. PubMed
  241. Wei M, et al. 2022. Front Immunol. 13:1017574. PubMed
  242. Xu H, et al. 2022. Aging Dis. 13:1875. PubMed
  243. Tan TCJ, et al. 2022. Nat Commun. 13:7796. PubMed
  244. Wang Z, et al. 2022. Cell Rep. 41:111890. PubMed
  245. Chan L, et al. 2022. Cells. 12: . PubMed
  246. Liu H, et al. 2023. Cell Death Differ. :. PubMed
  247. Mandour MF, et al. 2023. Front Med (Lausanne). 9:1057252. PubMed
  248. Kuehm LM, et al. 2021. Cancer Immunol Res. 9:227. PubMed
  249. Khojandi N, et al. 2021. Cancer Immunol Res. 9:214. PubMed
  250. Wight AE, et al. 2022. Proc Natl Acad Sci U S A. 119:e2200757119. PubMed
  251. Wu MJ, et al. 2022. Cancer Discov. 12:812. PubMed
  252. Tan L, et al. 2022. Aging Dis. 13:1562. PubMed
  253. Chen R, et al. 2022. J Mol Cell Biol. 14:. PubMed
  254. Cheng C, et al. 2022. Cell Mol Gastroenterol Hepatol. 15:261. PubMed
  255. Pan Y, et al. 2023. Adv Sci (Weinh). 10:e2206792. PubMed
  256. Wang X, et al. 2023. J Immunother Cancer. 11:. PubMed
  257. Lu C, et al. 2023. Antiviral Res. 212:105556. PubMed
  258. Zhuang WR, et al. 2023. Nat Commun. 14:1675. PubMed
  259. Tan X, et al. 2023. Adv Sci (Weinh). 10:e2206768. PubMed
  260. Martins Nascentes Melo L, et al. 2023. J Immunother Cancer. 11:. PubMed
  261. Li D, et al. 2023. Ann Med. 55:2189295. PubMed
  262. Zuo B, et al. 2023. Clin Transl Oncol. . PubMed
  263. Pandit M, et al. 2023. Nat Commun. 14:2593. PubMed
  264. Yu L, et al. 2023. Front Oncol. 13:1174713. PubMed
  265. Deng G, et al. 2023. Cancers (Basel). 15:. PubMed
  266. Wang Y, et al. 2023. iScience. 26:106630. PubMed
  267. Gao Y, et al. 2023. iScience. 26:106729. PubMed
  268. Vereertbrugghen A, et al. 2023. J Neuroinflammation. 20:120. PubMed
  269. Changsheng H, et al. 2023. Sci Adv. 9:eade4186. PubMed
  270. Yang QC, et al. 2023. iScience. 26:106916. PubMed
  271. Lin W, et al. 2020. Theranostics. 10:4871. PubMed
  272. Zhou J, et al. 2019. Immunity. 50:403. PubMed
  273. Shi L, et al. 2019. Theranostics. 9:4115. PubMed
  274. Alissafi T, et al. 2018. J Clin Invest. 128:3840. PubMed
  275. Gern BH, et al. 2021. Cell Host Microbe. 29(4):594-606.e6. PubMed
  276. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  277. Zhou J, et al. 2021. Int J Med Sci. 18:3516. PubMed
  278. Kim D, et al. 2021. Nanomicro Lett. 13:31. PubMed
  279. Gálvez-Cancino F, et al. 2017. Vaccine. 10.1016/j.vaccine.2017.06.041. PubMed
  280. Wang X, et al. 2018. Int Immunopharmacol. 56:249. PubMed
  281. Liu QZ, et al. 2018. Front Immunol. 1.131944444. PubMed
  282. Xia S, et al. 2014. J Leukoc Biol. 95:733. PubMed
  283. Su N, Xiong Y 2016. Sci Rep. 6:22658. PubMed
  284. Dong L, et al. 2021. Cancer Cell. . PubMed
  285. Yang F, et al. 2021. Front Microbiol. 11:512581. PubMed
  286. Kiritsy MC, et al. 2021. Elife. 10:. PubMed
  287. Stegelmeier AA, et al. 2022. Biomedicines. 10:. PubMed
  288. Chen L, et al. 2022. Mol Ther Oncolytics. 24:522. PubMed
  289. Liang S, et al. 2022. Acta Pharm Sin B. 12:2494. PubMed
  290. Coleby R, et al. 2021. Clin Exp Rheumatol. :39. PubMed
  291. Zhang S, et al. 2022. Cell Death Dis. 13:844. PubMed
  292. Chakrabarti J, et al. 2018. Oncotarget. 9:37439. PubMed
  293. Oyarce C, et al. 2018. Front Immunol. 8:1794. PubMed
  294. Tang Y, et al. 2020. Front Immunol. 11:585918. PubMed
  295. Mayer RL, et al. 2022. Nat Commun. 13:6075. PubMed
  296. Snyder LM, et al. 2021. PLoS Pathog. 17:e1009970. PubMed
  297. Nagatake T, et al. 2022. Mucosal Immunol. 15:289. PubMed
  298. Herman JD, et al. 2021. Nat Commun. 12:6853. PubMed
  299. Galeano Niño JL, et al. 2020. J Cell Sci. . PubMed
  300. Saito S, et al. 2020. Nutrients. 12:. PubMed
  301. Chen D, et al. 2018. Nat Commun. 9:873. PubMed
  302. Koenecke C, et al. 2012. J Immunol. 189:2890. PubMed
  303. Michel M, et al. 2012. Proc Natl Acad Sci U S A. 109:17459. PubMed
  304. Wang Y, et al. 2016. Sci Rep. 6:31881. PubMed
  305. Papafragkos I, et al. 2022. Front Immunol. 13:889075. PubMed
  306. Xiong A, et al. 2022. EBioMedicine. 83:104239. PubMed
  307. Pan W et al. 2017. Immunity. 47(2):284-297 . PubMed
  308. Ning X, et al. 2019. Mol Cell. 74:19. PubMed
  309. Uchimura T et al. 2018. Immunity. 49(6):1049-1061 . PubMed
  310. Lv H, et al. 2020. Cell Metabolism. 33(1):110-127.e5. PubMed
  311. Alissafi T, et al. 2020. Cell Metabolism. 32(4):591-604.e7. PubMed
  312. Sharma S, et al. 2015. J Immunol. 194:5529. PubMed
  313. Dai B, et al. 2022. Theranostics. 12:7603. PubMed
  314. Kuttke M, et al. 2022. Front Immunol. 13:695576. PubMed
  315. Xu X, et al. 2021. J Nanobiotechnology. 19:376. PubMed
  316. Subbiah J, et al. 2022. NPJ Vaccines. 7:68. PubMed
  317. Wang C, et al. 2021. Cell Rep. 37:110021. PubMed
  318. Uchil PD et al. 2018. Cell host & microbe. 25(1):87-100 . PubMed
  319. Probst P, et al. 2017. Cancer Res. 77:3644. PubMed
  320. Caronni N, et al. 2018. Cancer Res. 78:1685. PubMed
  321. Wan Y, et al. 2014. Vaccine. 41:241. PubMed
  322. Sandrock I, et al. 2015. PLoS One. 10: 0145010. PubMed
  323. Koren N, et al. 2021. Cell Host Microbe. 29(2):197-209.e5. PubMed
  324. An J, et al. 2022. iScience. 25:103570. PubMed
  325. Han JP, et al. 2022. Sci Adv. 8:eabj6901. PubMed
  326. Yu Y, et al. 2022. Nat Commun. 13:6357. PubMed
  327. Hegde S, et al. 2020. Cancer Cell. 37(3):289-307. PubMed
  328. Shami A, et al. 2015. Sci Rep. 5: 13904. PubMed
  329. Gungor B, et al. 2014. Sci Transl Med. 6:235. PubMed
  330. Srey MT, et al. 2020. PLoS Negl Trop Dis. 14:e0008842. PubMed
  331. Chen D, et al. 2022. J Neuroinflammation. 19:112. PubMed
  332. Cha SE, et al. 2021. Oncoimmunology. 10:1899469. PubMed
  333. Canton J, et al. 2021. Nat Immunol. 22:140. PubMed
  334. Espinosa JR, et al. 2018. Front Immunol. 9:1371. PubMed
  335. Hundt M, et al. 2009. J Immunol. 183:1685. PubMed
  336. Cho K, Hill A 2008. J Immunol Methods. 330:137. PubMed
  337. Condotta S, et al. 2015. J Immunol. 195: 116 - 125. PubMed
  338. Satoh M, et al. 2016. Sci Rep. 6:28473. PubMed
  339. Gong Y, et al. 2020. Cell Metabolism. 33(1):51-64.e9. PubMed
  340. Duan RN, et al. 2021. J Neuroinflammation. 18:145. PubMed
  341. Hanasoge Somasundara AV, et al. 2021. Cell Rep. 37:110099. PubMed
  342. Cheng B, et al. 2022. Cancer Commun (Lond). 42:17. PubMed
  343. Mirando AC, et al. 2020. Oncoimmunology. 9:1760685. PubMed
  344. Garo LP, et al. 2019. Cell Rep. 28:3353. PubMed
  345. Li W, et al. 2019. Nat Commun. 10:3349. PubMed
  346. Yan Y, et al. 2018. JCI Insight. 3. PubMed
  347. Place D, et al. 2017. PLoS One. 10.1371/journal.pone.0190384. PubMed
  348. Palazon A, et al. 2017. Cancer Cell. . 10.1016/j.ccell.2017.10.003. PubMed
  349. Brigas HC, et al. 2021. Cell Reports. 36(9):109574. PubMed
  350. Sartorius R, et al. 2015. EMBO Mol Med. 7: 973 - 988. PubMed
  351. Reese B, et al. 2020. J Immunol. 205:3218. PubMed
  352. Marcus A et al. 2018. Immunity. 49(4):754-763 . PubMed
  353. Ma Y, et al. 2013. J Immunol. 190:5588. PubMed
  354. Dutow P, et al. 2014. J Infect Dis. 209:1269. PubMed
  355. QT N, et al. 2015. Antimicrob Agents Chemother. 59: 6308-6316. PubMed
  356. Latasa C, et al. 2016. PLoS One. 11: 0161216. PubMed
  357. Holokai L, et al. 2020. Cancers (Basel). 12:00. PubMed
  358. Galeano Niño JL, et al. 2020. J Cell Sci. 133:00:00. PubMed
  359. Vaena S, et al. 2021. Cell Reports. 35(5):109076. PubMed
  360. Bosnjak B, et al. 2021. Front Immunol. 12:772240. PubMed
  361. Tian X, et al. 2022. J Cell Mol Med. 26:693. PubMed
  362. Kraus Z, et al. 2008. J Immunol. 181:7800. PubMed
  363. Lin W, et al. 2019. EBioMedicine. 49:133. PubMed
  364. Leclerc M, et al. 2019. Nat Commun. 10:3345. PubMed
  365. Nagatake T, et al. 2018. Int Immunol. 30:471. PubMed
  366. Chatterjee S et al. 2017. Cell metabolism. 27(1):85-100 . PubMed
  367. Yan J, et al. 2020. Cell Rep. 107820:31. PubMed
  368. Shen JZ, et al. 2020. Cell. 184(2):352-369.e23. PubMed
  369. Ren Y, et al. 2015. Sci Rep. 5: 18099. PubMed
  370. Yang Z, et al. 2021. Onco Targets Ther. 14:4239. PubMed
  371. De Ponte Conti B, et al. 2021. Elife. 10:. PubMed
  372. Tanaka Y, et al. 2020. Sci Rep. 10:17284. PubMed
  373. Ohtsuka J, et al. 2021. iScience. Online ahead of print. PubMed
  374. Lu J, et al. 2021. Cell Death Discov. 7:165. PubMed
  375. Karandikar SH, et al. 2019. JCI Insight. 5. PubMed
  376. Bartolacci C, et al. 2018. Cancer Immunol Res. 1.281944444. PubMed
  377. Montfort M, et al. 2004. J Immunol. 173:4084. PubMed
  378. Koelwyn GJ, et al. 2020. Nat Med. 1452:26. PubMed
  379. Xu P, et al. 2020. Cancer Immunol Res. 8:1193. PubMed
  380. Xu Q, et al. 2021. Theranostics. 11:1937. PubMed
  381. Guo S, et al. 2021. Sci Rep. 11:23745. PubMed
  382. Kalafati L, et al. 2020. Cell. 183:771. PubMed
  383. Roy S, et al. 2019. Front Immunol. 2.404166667. PubMed
  384. Yuan X, et al. 2017. Elife. 6:e29540. PubMed
  385. Nagatake T, et al. 2018. J Allergy Clin Immunol. 142:470. PubMed
  386. Zhang J, et al. 2018. Nature. 553:91. PubMed
  387. Wang Y, et al. 2020. Virol Sin. 36:122. PubMed
  388. Hirata SI, et al. 2020. Allergy. 75:1939. PubMed
  389. Castiglioni P, et al. 2017. PLoS Negl Trop Dis. 10.1371/journal.pntd.0005240. PubMed
  390. Dong M, et al. 2022. J Immunother Cancer. 10:. PubMed
  391. Ye Q, et al. 2022. NPJ Vaccines. 7:84. PubMed
  392. Stephens WZ, et al. 2021. Cell Rep. 37:109916. PubMed
  393. Raju S, et al. 2020. Cell Reports. 29(9):2556-2564.e3.. PubMed
  394. Mandour MF, et al. 2020. Infect Agent Cancer. 15:30. PubMed
  395. Miura N, et al. 2017. Mol Ther. 10.1016/j.ymthe.2017.01.020. PubMed
  396. Miao W, et al. 2020. J Immunol. 1486:204. PubMed
  397. Cartwright ANR, et al. 2021. Cancer Immunol Res. 9:470. PubMed
  398. Li H, et al. 2021. Front Immunol. 12:739605. PubMed
  399. Kiritsy MC, et al. 2021. Elife. 10:. PubMed
  400. Tian D, et al. 2019. Nat Commun. 10:4246. PubMed
  401. Mah-Som AY, et al. 2021. Cell Reports. 35(9):109209. PubMed
  402. Lee J, et al. 2007. Nat Immunol. 8:181. PubMed
  403. Ma Q, et al. 2022. Vaccines (Basel). 10:. PubMed
  404. Kim MY, et al. 2022. Nat Commun. 13:3296. PubMed
  405. Johnson RM, et al. 2021. Front Immunol. 11:614697. PubMed
  406. Ding L et al. 2018. Cell reports. 25(11):2972-2980 . PubMed
  407. Tomaru U et al. 2019. Cell reports. 26(3):639-651 . PubMed
  408. Hoechst B, et al. 2016. J Immunol. 195:1517-1523. PubMed
  409. Molgora M, et al. 2020. Cell. 182:886. PubMed
  410. Fang W, et al. 2021. J Exp Clin Cancer Res. 40:4. PubMed
  411. Chen L, et al. 2021. Theranostics. 11:6668. PubMed
  412. Rousso-Noori L, et al. 2021. Nat Commun. 12:3615. PubMed
  413. Wang Y, et al. 2021. Front Immunol. 11:601601. PubMed
  414. Prakash MD, et al. 2021. PLoS One. 16:e0247492. PubMed
  415. Zhang X, et al. 2020. J Cancer. 11:648. PubMed
  416. Chakraborty P, et al. 2020. Cell Reports. 28(7):1879-1893.e7.. PubMed
  417. Zhao K, et al. 2021. Biomed Res Int. 7619849:2020. PubMed
  418. Charlton J, et al. 2015. PLoS One. 10:119200. PubMed
  419. Nakao R, et al. 2022. NPJ Vaccines. 7:153. PubMed
  420. McAusland TM, et al. 2021. Mol Ther Oncolytics. 20:306. PubMed
  421. Li H, et al. 2022. iScience. 25:104481. PubMed
  422. Schmit T, et al. 2022. Cell Rep. 38:110456. PubMed
  423. Zhang X, et al. 2021. Front Pharmacol. 12:706748. PubMed
  424. Liu X, et al. 2021. Adv Sci (Weinh). 8:e2100233. PubMed
  425. Timilshina M, et al. 2020. Cell Reports. 27(10):2948-2961.e7.. PubMed
  426. Kim YS, et al. 2018. Front Immunol. 9:1093. PubMed
  427. Wang N, et al. 2020. Front Immunol. 1.765972222. PubMed
  428. Gaylo A, et al. 2013. Transpl Immunol. 20:163. PubMed
  429. Dourcy M, et al. 2020. Mucosal Immunol. 13:799. PubMed
  430. Kerdidani D, et al. 2022. J Exp Med. 219:. PubMed
  431. Zheng Y, et al. 2022. Transl Res. :. PubMed
  432. Brenner E, et al. 2020. Nat Commun. 11:1335. PubMed
  433. Qi S, et al. 2020. Theranostics. 10:1814. PubMed
  434. Chen S, et al. 2018. Nat Commun. 9:5298. PubMed
  435. Bing Wu et al. 2018. Immunity. 49(5):886-898 . PubMed
  436. Nabekura T, et al. 2020. Immunity. 96:52. PubMed
  437. Chow AK, et al. 2021. Cellular and Molecular Gastroenterology and Hepatology. :. PubMed
  438. Tripathi D, et al. 2016. Nat Commun. 7:13896. PubMed
  439. Chen PM, et al. 2022. Sci Adv. 8:eabo4271. PubMed
  440. Song X, et al. 2022. Transl Oncol. 15:101306. PubMed
  441. Yang F, et al. 2021. Nat Commun. 12:3424. PubMed
  442. Li X, et al. 2021. Front Cell Dev Biol. 9:647713. PubMed
RRID
AB_315401 (BioLegend Cat. No. 505807)
AB_315402 (BioLegend Cat. No. 505808)

Antigen Details

Structure
Cytokine; dimer; 40-80 kD (Mammalian)
Bioactivity
Antiviral/antiparasitic activities; inhibits proliferation; enhances MHC class I and II expression on APCs
Cell Sources
CD8+ and CD4+ T cells, NK cells
Cell Targets
T cells, B cells, macrophages, NK cells, endothelial cells, fibroblasts
Receptors
IFN-γRα (CDw119) dimerized with IFN-γRβ (AF-1)
Cell Type
Tregs
Biology Area
Cell Biology, Immunology, Neuroinflammation, Neuroscience
Molecular Family
Cytokines/Chemokines
Antigen References

1. Fitzgerald K, et al. Eds. 2001. The Cytokine FactsBook. Academic Press, San Diego.
2. De Maeyer E, et al. 1992. Curr. Opin. Immunol. 4:321.
3. Farrar M, et al. 1993. Annu. Rev. Immunol. 11:571.
4. Gray P, et al. 1987. Lymphokines 13:151.

Regulation
Upregulated by IL-2, FGF-basic, EGF; downregulated by 1-α-25-Dihydroxy vitamin D3, dexamethasone
Gene ID
15978 View all products for this Gene ID
UniProt
View information about IFN-gamma on UniProt.org

Related FAQs

What type of PE do you use in your conjugates?
We use R-PE in our conjugates.

Other Formats

View All IFN-γ Reagents Request Custom Conjugation
Description Clone Applications
Alexa Fluor® 700 anti-mouse IFN-γ XMG1.2 ICFC
APC/Cyanine7 anti-mouse IFN-γ XMG1.2 ICFC
GoInVivo™ Purified anti-mouse IFN-γ XMG1.2 ELISA Capture,ELISPOT Capture,CyTOF®,Neut,ICFC,IHC,WB
APC/Fire™ 750 anti-mouse IFN-γ XMG1.2 ICFC
APC anti-mouse IFN-γ XMG1.2 ICFC
Biotin anti-mouse IFN-γ XMG1.2 ELISA Detection,ELISPOT Detection,ICFC
FITC anti-mouse IFN-γ XMG1.2 ICFC
PE anti-mouse IFN-γ XMG1.2 ICFC
Purified anti-mouse IFN-γ XMG1.2 ELISA Capture,CyTOF®,IHC,WB
Alexa Fluor® 488 anti-mouse IFN-γ XMG1.2 ICFC
Alexa Fluor® 647 anti-mouse IFN-γ XMG1.2 ICFC
Pacific Blue™ anti-mouse IFN-γ XMG1.2 ICFC
PerCP/Cyanine5.5 anti-mouse IFN-γ XMG1.2 ICFC
PE/Cyanine7 anti-mouse IFN-γ XMG1.2 ICFC
Brilliant Violet 421™ anti-mouse IFN-γ XMG1.2 ICFC
Brilliant Violet 650™ anti-mouse IFN-γ XMG1.2 ICFC
Ultra-LEAF™ Purified anti-mouse IFN-γ XMG1.2 ELISA Capture,ELISPOT Capture,CyTOF®,Neut,ICFC,IHC,WB
Brilliant Violet 711™ anti-mouse IFN-γ XMG1.2 ICFC
Brilliant Violet 785™ anti-mouse IFN-γ XMG1.2 ICFC
Brilliant Violet 605™ anti-mouse IFN-γ XMG1.2 ICFC
Brilliant Violet 510™ anti-mouse IFN-γ XMG1.2 ICFC
Purified anti-mouse IFN-γ (Maxpar® Ready) XMG1.2 ELISA Capture,CyTOF®
PE/Dazzle™ 594 anti-mouse IFN-γ XMG1.2 ICFC
Spark NIR™ 685 anti-mouse IFN-γ XMG1.2 ICFC
Spark UV™ 387 anti-mouse IFN-γ XMG1.2 ICFC
Brilliant Violet 750™ anti-mouse IFN-γ XMG1.2 ICFC
TotalSeq™-C1526 anti-mouse IFN-γ Antibody XMG1.2 ICPG
Go To Top Version: 2    Revision Date: 12.11.2012

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

Pricing & Availability
Clone
XMG1.2 (See other available formats)
Regulatory Status
RUO
Other Names
Interferon-γ, Immune interferon, Type II interferon, T cell interferon, Macrophage-activating factor (MAF)
Isotype
Rat IgG1, κ
Ave. Rating
Submit a Review
Product Citations
publications
XMG1.2
PMA/Ionomycin-stimulated BALB/c T-cells were stained with CD3 FITC and XMG1.2 PE
  • XMG1.2
    PMA/Ionomycin-stimulated BALB/c T-cells were stained with CD3 FITC and XMG1.2 PE
Compare all formats See PE spectral data
Cat # Size Price Quantity Check Availability Save
505807 25 µg NOK322
Check Availability


Need larger quantities of this item?
Request Bulk Quote
505808 100 µg NOK908
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

IFN-γ is a potent multifunctional cytokine which is secreted primarily by activated NK cells and T cells. Originally characterized based on anti-viral activities, IFN-γ also exerts anti-proliferative, immunoregulatory, and proinflammatory activities. IFN-γ can upregulate MHC class I and II antigen expression by antigen-presenting cells.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
E. coli-expressed, recombinant mouse IFN-γ
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The IFN-γ antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

ICFC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by intracellular immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤0.25 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

ELISA1-4,11,14 or ELISPOT5 Detection: The biotinylated XMG1.2 antibody is useful as a detection antibody for a sandwich ELISA or ELISPOT assay, when used in conjunction with purified R4-6A2 antibody (Cat. No. 505702/505706) as the capture antibody and recombinant mouse IFN-γ (Cat. No. 575309) as the standard.
ELISA or ELISPOT Capture: The purified XMG1.2 antibody is useful as a capture antibody for a sandwich ELISA or ELISPOT assay, when used in conjunction with biotinylated R4-6A2 antibody (Cat. No. 505704) as the detection antibody and recombinant mouse IFN-γ (Cat. No. 575309) as the standard. The LEAF™ purified antibody is suggested for ELISPOT capture (Cat. No. 505812).
Flow Cytometry7,8,12,13,16: The fluorochrome-labeled XMG1.2 antibody is useful for intracellular immunofluorescent staining and flow cytometric analysis to identify IFN-γ-producing cells within mixed cell populations.
Neutralization1-3,9,10: The XMG1.2 antibody can neutralize the bioactivity of natural or recombinant IFN-γ. The LEAF™ purified antibody (Endotoxin <0.1 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for neutralization of mouse IFN-γ bioactivity in vivo and in vitro (Cat. No. 505812). For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Cat. No. 505834) with a lower endotoxin limit than standard LEAF™ purified antibodies (Endotoxin <0.01 EU/µg).
Additional reported applications (for the relevant formats) include: Western blotting, immunohistochemical staining of frozen tissue sections6,22,23, and immunocytochemistry.
Note: For testing mouse IFN-γ in serum, plasma or supernatant, BioLegend's ELISA Max™ Sets (Cat. No. 430801 to 430806) are specially developed and recommended.

Application References
  1. Abrams J, et al. 1992. Immunol. Rev. 127:5. (ELISA, Neut)
  2. Sander B, et al. 1993. J. Immunol. Meth. 166:201. (ELISA, Neut)
  3. Abrams J, et al. 1995. Curr. Prot. Immunol. John Wiley and Sons, New York. Unit 6.20. (ELISA, Neut)
  4. Yang X, et al. 1993. J. Immunoassay 14:129. (ELISA)
  5. Klinman D, et al. 1994. Curr. Prot. Immunol. John Wiley and Sons, New York. Unit 6.19. (ELISPOT)
  6. Sander B, et al. 1991. Immunol. Rev. 119:65. (IHC)
  7. Ferrick D, et al. 1995. Nature 373:255. (FC)
  8. Ko SY, et al. 2005. J. Immunol. 175:3309. (FC) PubMed
  9. Peterson KE, et al. 2000. J. Virol. 74:5363. (Neut)
  10. DeKrey GK, et al. 1998. Infect. Immun. 66:827. (Neut)
  11. Dzhagalov I, et al. 2007. J. Immunol. 178:2113. (ELISA)
  12. Lawson BR, et al. 2007. J. Immunol. 178:5366. (FC)
  13. Lee JW, et al. 2006. Nature Immunol. 8:181. (FC) PubMed
  14. Xu G, et al. 2007. J. Immunol. 179:5358. (ELISA) PubMed
  15. Montfort M, et al.2004. J. Immunol. 173:4084. PubMed
  16. Haring JS, et al. 2008. J. Immunol. 180:2855. (FC) PubMed
  17. Jordan JM, et al. 2008. Infect Immun. 76:3717. PubMed
  18. Tonkin DR, et al. 2008. J. Immunol. 181:4516. PubMed
  19. Charles N, et al. 2010. Nat. Med. 16:701. (FC) PubMed
  20. Cui Y, et al. 2009. Invest. Ophth. Vis. Sci. 50:5811. (FC) PubMed
  21. Mykkanen OT, et al. 2014. PLoS One. 9:114790. PubMed
  22. Yokogawa M, et al. 2013. Mol. Carcinog. 52:760. (IHC)
  23. Mottram PL, et al. 1998. J Immunol. 161:602. (IHC)
Product Citations
  1. Bradley CP et al. 2017. Cell host & microbe. 22(5):697-704 . PubMed
  2. Wu J et al. 2017. Immunity. 47(6):1114-1128 . PubMed
  3. Toubai T, et al. 2017. Blood Adv. 1.095138889. PubMed
  4. Yu X, et al. 2020. Nat Commun. 11:1110. PubMed
  5. Wang H, et al. 2013. J Immunol. 191:6010. PubMed
  6. Kim K, et al. 2016. PLoS One. 11: 0148576. PubMed
  7. Liu Y, et al. 2021. Cell Metabolism. 33(6):1221-1233.e11. PubMed
  8. Chen Y, et al. 2020. Virol Sin. . PubMed
  9. Sandu I, et al. 2020. Nat Commun. 11:4454. PubMed
  10. Wang HH, et al. 2022. J Biomed Sci. 29:36. PubMed
  11. Miki H, et al. 2020. J Immunol. 204:1892. PubMed
  12. Zhang H, et al. 2022. Eur J Immunol. 52:978. PubMed
  13. Jia JJ, et al. 2022. J Leukoc Biol. 112:157. PubMed
  14. Chakraborty P, et al. 2022. Cancer Res. 82:1969. PubMed
  15. Lu R, et al. 2022. Scand J Immunol. 96:e13177. PubMed
  16. Tu J, et al. 2022. Cancer Sci. 113:2496. PubMed
  17. Liu H, et al. 2022. Cell Rep Med. 3:100660. PubMed
  18. Backlund C, et al. 2022. Proc Natl Acad Sci U S A. 119:e2204078119. PubMed
  19. Kang IH, et al. 2022. iScience. 25:104818. PubMed
  20. Wei M, et al. 2022. Front Immunol. 13:1017574. PubMed
  21. Xu H, et al. 2022. Aging Dis. 13:1875. PubMed
  22. Tan TCJ, et al. 2022. Nat Commun. 13:7796. PubMed
  23. Wang Z, et al. 2022. Cell Rep. 41:111890. PubMed
  24. Chan L, et al. 2022. Cells. 12: . PubMed
  25. Liu H, et al. 2023. Cell Death Differ. :. PubMed
  26. Mandour MF, et al. 2023. Front Med (Lausanne). 9:1057252. PubMed
  27. Kuehm LM, et al. 2021. Cancer Immunol Res. 9:227. PubMed
  28. Khojandi N, et al. 2021. Cancer Immunol Res. 9:214. PubMed
  29. Wight AE, et al. 2022. Proc Natl Acad Sci U S A. 119:e2200757119. PubMed
  30. Wu MJ, et al. 2022. Cancer Discov. 12:812. PubMed
  31. Tan L, et al. 2022. Aging Dis. 13:1562. PubMed
  32. Chen R, et al. 2022. J Mol Cell Biol. 14:. PubMed
  33. Cheng C, et al. 2022. Cell Mol Gastroenterol Hepatol. 15:261. PubMed
  34. Pan Y, et al. 2023. Adv Sci (Weinh). 10:e2206792. PubMed
  35. Wang X, et al. 2023. J Immunother Cancer. 11:. PubMed
  36. Lu C, et al. 2023. Antiviral Res. 212:105556. PubMed
  37. Zhuang WR, et al. 2023. Nat Commun. 14:1675. PubMed
  38. Tan X, et al. 2023. Adv Sci (Weinh). 10:e2206768. PubMed
  39. Martins Nascentes Melo L, et al. 2023. J Immunother Cancer. 11:. PubMed
  40. Li D, et al. 2023. Ann Med. 55:2189295. PubMed
  41. Zuo B, et al. 2023. Clin Transl Oncol. . PubMed
  42. Pandit M, et al. 2023. Nat Commun. 14:2593. PubMed
  43. Yu L, et al. 2023. Front Oncol. 13:1174713. PubMed
  44. Deng G, et al. 2023. Cancers (Basel). 15:. PubMed
  45. Wang Y, et al. 2023. iScience. 26:106630. PubMed
  46. Gao Y, et al. 2023. iScience. 26:106729. PubMed
  47. Vereertbrugghen A, et al. 2023. J Neuroinflammation. 20:120. PubMed
  48. Changsheng H, et al. 2023. Sci Adv. 9:eade4186. PubMed
  49. Yang QC, et al. 2023. iScience. 26:106916. PubMed
  50. Lin W, et al. 2020. Theranostics. 10:4871. PubMed
  51. Zhou J, et al. 2019. Immunity. 50:403. PubMed
  52. Shi L, et al. 2019. Theranostics. 9:4115. PubMed
  53. Alissafi T, et al. 2018. J Clin Invest. 128:3840. PubMed
  54. Gern BH, et al. 2021. Cell Host Microbe. 29(4):594-606.e6. PubMed
  55. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  56. Zhou J, et al. 2021. Int J Med Sci. 18:3516. PubMed
  57. Kim D, et al. 2021. Nanomicro Lett. 13:31. PubMed
  58. Gálvez-Cancino F, et al. 2017. Vaccine. 10.1016/j.vaccine.2017.06.041. PubMed
  59. Wang X, et al. 2018. Int Immunopharmacol. 56:249. PubMed
  60. Liu QZ, et al. 2018. Front Immunol. 1.131944444. PubMed
  61. Xia S, et al. 2014. J Leukoc Biol. 95:733. PubMed
  62. Su N, Xiong Y 2016. Sci Rep. 6:22658. PubMed
  63. Dong L, et al. 2021. Cancer Cell. . PubMed
  64. Yang F, et al. 2021. Front Microbiol. 11:512581. PubMed
  65. Kiritsy MC, et al. 2021. Elife. 10:. PubMed
  66. Stegelmeier AA, et al. 2022. Biomedicines. 10:. PubMed
  67. Chen L, et al. 2022. Mol Ther Oncolytics. 24:522. PubMed
  68. Liang S, et al. 2022. Acta Pharm Sin B. 12:2494. PubMed
  69. Coleby R, et al. 2021. Clin Exp Rheumatol. :39. PubMed
  70. Zhang S, et al. 2022. Cell Death Dis. 13:844. PubMed
  71. Chakrabarti J, et al. 2018. Oncotarget. 9:37439. PubMed
  72. Oyarce C, et al. 2018. Front Immunol. 8:1794. PubMed
  73. Tang Y, et al. 2020. Front Immunol. 11:585918. PubMed
  74. Mayer RL, et al. 2022. Nat Commun. 13:6075. PubMed
  75. Snyder LM, et al. 2021. PLoS Pathog. 17:e1009970. PubMed
  76. Nagatake T, et al. 2022. Mucosal Immunol. 15:289. PubMed
  77. Herman JD, et al. 2021. Nat Commun. 12:6853. PubMed
  78. Galeano Niño JL, et al. 2020. J Cell Sci. . PubMed
  79. Saito S, et al. 2020. Nutrients. 12:. PubMed
  80. Chen D, et al. 2018. Nat Commun. 9:873. PubMed
  81. Koenecke C, et al. 2012. J Immunol. 189:2890. PubMed
  82. Michel M, et al. 2012. Proc Natl Acad Sci U S A. 109:17459. PubMed
  83. Wang Y, et al. 2016. Sci Rep. 6:31881. PubMed
  84. Papafragkos I, et al. 2022. Front Immunol. 13:889075. PubMed
  85. Xiong A, et al. 2022. EBioMedicine. 83:104239. PubMed
  86. Pan W et al. 2017. Immunity. 47(2):284-297 . PubMed
  87. Ning X, et al. 2019. Mol Cell. 74:19. PubMed
  88. Uchimura T et al. 2018. Immunity. 49(6):1049-1061 . PubMed
  89. Lv H, et al. 2020. Cell Metabolism. 33(1):110-127.e5. PubMed
  90. Alissafi T, et al. 2020. Cell Metabolism. 32(4):591-604.e7. PubMed
  91. Sharma S, et al. 2015. J Immunol. 194:5529. PubMed
  92. Dai B, et al. 2022. Theranostics. 12:7603. PubMed
  93. Kuttke M, et al. 2022. Front Immunol. 13:695576. PubMed
  94. Xu X, et al. 2021. J Nanobiotechnology. 19:376. PubMed
  95. Subbiah J, et al. 2022. NPJ Vaccines. 7:68. PubMed
  96. Wang C, et al. 2021. Cell Rep. 37:110021. PubMed
  97. Uchil PD et al. 2018. Cell host & microbe. 25(1):87-100 . PubMed
  98. Probst P, et al. 2017. Cancer Res. 77:3644. PubMed
  99. Caronni N, et al. 2018. Cancer Res. 78:1685. PubMed
  100. Wan Y, et al. 2014. Vaccine. 41:241. PubMed
  101. Sandrock I, et al. 2015. PLoS One. 10: 0145010. PubMed
  102. Koren N, et al. 2021. Cell Host Microbe. 29(2):197-209.e5. PubMed
  103. An J, et al. 2022. iScience. 25:103570. PubMed
  104. Han JP, et al. 2022. Sci Adv. 8:eabj6901. PubMed
  105. Yu Y, et al. 2022. Nat Commun. 13:6357. PubMed
  106. Hegde S, et al. 2020. Cancer Cell. 37(3):289-307. PubMed
  107. Shami A, et al. 2015. Sci Rep. 5: 13904. PubMed
  108. Gungor B, et al. 2014. Sci Transl Med. 6:235. PubMed
  109. Srey MT, et al. 2020. PLoS Negl Trop Dis. 14:e0008842. PubMed
  110. Chen D, et al. 2022. J Neuroinflammation. 19:112. PubMed
  111. Cha SE, et al. 2021. Oncoimmunology. 10:1899469. PubMed
  112. Canton J, et al. 2021. Nat Immunol. 22:140. PubMed
  113. Espinosa JR, et al. 2018. Front Immunol. 9:1371. PubMed
  114. Hundt M, et al. 2009. J Immunol. 183:1685. PubMed
  115. Cho K, Hill A 2008. J Immunol Methods. 330:137. PubMed
  116. Condotta S, et al. 2015. J Immunol. 195: 116 - 125. PubMed
  117. Satoh M, et al. 2016. Sci Rep. 6:28473. PubMed
  118. Gong Y, et al. 2020. Cell Metabolism. 33(1):51-64.e9. PubMed
  119. Duan RN, et al. 2021. J Neuroinflammation. 18:145. PubMed
  120. Hanasoge Somasundara AV, et al. 2021. Cell Rep. 37:110099. PubMed
  121. Cheng B, et al. 2022. Cancer Commun (Lond). 42:17. PubMed
  122. Mirando AC, et al. 2020. Oncoimmunology. 9:1760685. PubMed
  123. Garo LP, et al. 2019. Cell Rep. 28:3353. PubMed
  124. Li W, et al. 2019. Nat Commun. 10:3349. PubMed
  125. Yan Y, et al. 2018. JCI Insight. 3. PubMed
  126. Place D, et al. 2017. PLoS One. 10.1371/journal.pone.0190384. PubMed
  127. Palazon A, et al. 2017. Cancer Cell. . 10.1016/j.ccell.2017.10.003. PubMed
  128. Brigas HC, et al. 2021. Cell Reports. 36(9):109574. PubMed
  129. Sartorius R, et al. 2015. EMBO Mol Med. 7: 973 - 988. PubMed
  130. Reese B, et al. 2020. J Immunol. 205:3218. PubMed
  131. Marcus A et al. 2018. Immunity. 49(4):754-763 . PubMed
  132. Ma Y, et al. 2013. J Immunol. 190:5588. PubMed
  133. Dutow P, et al. 2014. J Infect Dis. 209:1269. PubMed
  134. QT N, et al. 2015. Antimicrob Agents Chemother. 59: 6308-6316. PubMed
  135. Latasa C, et al. 2016. PLoS One. 11: 0161216. PubMed
  136. Holokai L, et al. 2020. Cancers (Basel). 12:00. PubMed
  137. Galeano Niño JL, et al. 2020. J Cell Sci. 133:00:00. PubMed
  138. Vaena S, et al. 2021. Cell Reports. 35(5):109076. PubMed
  139. Bosnjak B, et al. 2021. Front Immunol. 12:772240. PubMed
  140. Tian X, et al. 2022. J Cell Mol Med. 26:693. PubMed
  141. Kraus Z, et al. 2008. J Immunol. 181:7800. PubMed
  142. Lin W, et al. 2019. EBioMedicine. 49:133. PubMed
  143. Leclerc M, et al. 2019. Nat Commun. 10:3345. PubMed
  144. Nagatake T, et al. 2018. Int Immunol. 30:471. PubMed
  145. Chatterjee S et al. 2017. Cell metabolism. 27(1):85-100 . PubMed
  146. Yan J, et al. 2020. Cell Rep. 107820:31. PubMed
  147. Shen JZ, et al. 2020. Cell. 184(2):352-369.e23. PubMed
  148. Ren Y, et al. 2015. Sci Rep. 5: 18099. PubMed
  149. Yang Z, et al. 2021. Onco Targets Ther. 14:4239. PubMed
  150. De Ponte Conti B, et al. 2021. Elife. 10:. PubMed
  151. Tanaka Y, et al. 2020. Sci Rep. 10:17284. PubMed
  152. Ohtsuka J, et al. 2021. iScience. Online ahead of print. PubMed
  153. Lu J, et al. 2021. Cell Death Discov. 7:165. PubMed
  154. Karandikar SH, et al. 2019. JCI Insight. 5. PubMed
  155. Bartolacci C, et al. 2018. Cancer Immunol Res. 1.281944444. PubMed
  156. Montfort M, et al. 2004. J Immunol. 173:4084. PubMed
  157. Koelwyn GJ, et al. 2020. Nat Med. 1452:26. PubMed
  158. Xu P, et al. 2020. Cancer Immunol Res. 8:1193. PubMed
  159. Xu Q, et al. 2021. Theranostics. 11:1937. PubMed
  160. Guo S, et al. 2021. Sci Rep. 11:23745. PubMed
  161. Kalafati L, et al. 2020. Cell. 183:771. PubMed
  162. Roy S, et al. 2019. Front Immunol. 2.404166667. PubMed
  163. Yuan X, et al. 2017. Elife. 6:e29540. PubMed
  164. Nagatake T, et al. 2018. J Allergy Clin Immunol. 142:470. PubMed
  165. Zhang J, et al. 2018. Nature. 553:91. PubMed
  166. Wang Y, et al. 2020. Virol Sin. 36:122. PubMed
  167. Hirata SI, et al. 2020. Allergy. 75:1939. PubMed
  168. Castiglioni P, et al. 2017. PLoS Negl Trop Dis. 10.1371/journal.pntd.0005240. PubMed
  169. Dong M, et al. 2022. J Immunother Cancer. 10:. PubMed
  170. Ye Q, et al. 2022. NPJ Vaccines. 7:84. PubMed
  171. Stephens WZ, et al. 2021. Cell Rep. 37:109916. PubMed
  172. Raju S, et al. 2020. Cell Reports. 29(9):2556-2564.e3.. PubMed
  173. Mandour MF, et al. 2020. Infect Agent Cancer. 15:30. PubMed
  174. Miura N, et al. 2017. Mol Ther. 10.1016/j.ymthe.2017.01.020. PubMed
  175. Miao W, et al. 2020. J Immunol. 1486:204. PubMed
  176. Cartwright ANR, et al. 2021. Cancer Immunol Res. 9:470. PubMed
  177. Li H, et al. 2021. Front Immunol. 12:739605. PubMed
  178. Kiritsy MC, et al. 2021. Elife. 10:. PubMed
  179. Tian D, et al. 2019. Nat Commun. 10:4246. PubMed
  180. Mah-Som AY, et al. 2021. Cell Reports. 35(9):109209. PubMed
  181. Lee J, et al. 2007. Nat Immunol. 8:181. PubMed
  182. Ma Q, et al. 2022. Vaccines (Basel). 10:. PubMed
  183. Kim MY, et al. 2022. Nat Commun. 13:3296. PubMed
  184. Johnson RM, et al. 2021. Front Immunol. 11:614697. PubMed
  185. Ding L et al. 2018. Cell reports. 25(11):2972-2980 . PubMed
  186. Tomaru U et al. 2019. Cell reports. 26(3):639-651 . PubMed
  187. Hoechst B, et al. 2016. J Immunol. 195:1517-1523. PubMed
  188. Molgora M, et al. 2020. Cell. 182:886. PubMed
  189. Fang W, et al. 2021. J Exp Clin Cancer Res. 40:4. PubMed
  190. Chen L, et al. 2021. Theranostics. 11:6668. PubMed
  191. Rousso-Noori L, et al. 2021. Nat Commun. 12:3615. PubMed
  192. Wang Y, et al. 2021. Front Immunol. 11:601601. PubMed
  193. Prakash MD, et al. 2021. PLoS One. 16:e0247492. PubMed
  194. Zhang X, et al. 2020. J Cancer. 11:648. PubMed
  195. Chakraborty P, et al. 2020. Cell Reports. 28(7):1879-1893.e7.. PubMed
  196. Zhao K, et al. 2021. Biomed Res Int. 7619849:2020. PubMed
  197. Charlton J, et al. 2015. PLoS One. 10:119200. PubMed
  198. Nakao R, et al. 2022. NPJ Vaccines. 7:153. PubMed
  199. McAusland TM, et al. 2021. Mol Ther Oncolytics. 20:306. PubMed
  200. Li H, et al. 2022. iScience. 25:104481. PubMed
  201. Schmit T, et al. 2022. Cell Rep. 38:110456. PubMed
  202. Zhang X, et al. 2021. Front Pharmacol. 12:706748. PubMed
  203. Liu X, et al. 2021. Adv Sci (Weinh). 8:e2100233. PubMed
  204. Timilshina M, et al. 2020. Cell Reports. 27(10):2948-2961.e7.. PubMed
  205. Kim YS, et al. 2018. Front Immunol. 9:1093. PubMed
  206. Wang N, et al. 2020. Front Immunol. 1.765972222. PubMed
  207. Gaylo A, et al. 2013. Transpl Immunol. 20:163. PubMed
  208. Dourcy M, et al. 2020. Mucosal Immunol. 13:799. PubMed
  209. Kerdidani D, et al. 2022. J Exp Med. 219:. PubMed
  210. Zheng Y, et al. 2022. Transl Res. :. PubMed
  211. Brenner E, et al. 2020. Nat Commun. 11:1335. PubMed
  212. Qi S, et al. 2020. Theranostics. 10:1814. PubMed
  213. Chen S, et al. 2018. Nat Commun. 9:5298. PubMed
  214. Bing Wu et al. 2018. Immunity. 49(5):886-898 . PubMed
  215. Nabekura T, et al. 2020. Immunity. 96:52. PubMed
  216. Chow AK, et al. 2021. Cellular and Molecular Gastroenterology and Hepatology. :. PubMed
  217. Tripathi D, et al. 2016. Nat Commun. 7:13896. PubMed
  218. Chen PM, et al. 2022. Sci Adv. 8:eabo4271. PubMed
  219. Song X, et al. 2022. Transl Oncol. 15:101306. PubMed
  220. Yang F, et al. 2021. Nat Commun. 12:3424. PubMed
  221. Li X, et al. 2021. Front Cell Dev Biol. 9:647713. PubMed
  222. Bradley CP et al. 2017. Cell host & microbe. 22(5):697-704 . PubMed
  223. Wu J et al. 2017. Immunity. 47(6):1114-1128 . PubMed
  224. Toubai T, et al. 2017. Blood Adv. 1.095138889. PubMed
  225. Yu X, et al. 2020. Nat Commun. 11:1110. PubMed
  226. Wang H, et al. 2013. J Immunol. 191:6010. PubMed
  227. Kim K, et al. 2016. PLoS One. 11: 0148576. PubMed
  228. Liu Y, et al. 2021. Cell Metabolism. 33(6):1221-1233.e11. PubMed
  229. Chen Y, et al. 2020. Virol Sin. . PubMed
  230. Sandu I, et al. 2020. Nat Commun. 11:4454. PubMed
  231. Wang HH, et al. 2022. J Biomed Sci. 29:36. PubMed
  232. Miki H, et al. 2020. J Immunol. 204:1892. PubMed
  233. Zhang H, et al. 2022. Eur J Immunol. 52:978. PubMed
  234. Jia JJ, et al. 2022. J Leukoc Biol. 112:157. PubMed
  235. Chakraborty P, et al. 2022. Cancer Res. 82:1969. PubMed
  236. Lu R, et al. 2022. Scand J Immunol. 96:e13177. PubMed
  237. Tu J, et al. 2022. Cancer Sci. 113:2496. PubMed
  238. Liu H, et al. 2022. Cell Rep Med. 3:100660. PubMed
  239. Backlund C, et al. 2022. Proc Natl Acad Sci U S A. 119:e2204078119. PubMed
  240. Kang IH, et al. 2022. iScience. 25:104818. PubMed
  241. Wei M, et al. 2022. Front Immunol. 13:1017574. PubMed
  242. Xu H, et al. 2022. Aging Dis. 13:1875. PubMed
  243. Tan TCJ, et al. 2022. Nat Commun. 13:7796. PubMed
  244. Wang Z, et al. 2022. Cell Rep. 41:111890. PubMed
  245. Chan L, et al. 2022. Cells. 12: . PubMed
  246. Liu H, et al. 2023. Cell Death Differ. :. PubMed
  247. Mandour MF, et al. 2023. Front Med (Lausanne). 9:1057252. PubMed
  248. Kuehm LM, et al. 2021. Cancer Immunol Res. 9:227. PubMed
  249. Khojandi N, et al. 2021. Cancer Immunol Res. 9:214. PubMed
  250. Wight AE, et al. 2022. Proc Natl Acad Sci U S A. 119:e2200757119. PubMed
  251. Wu MJ, et al. 2022. Cancer Discov. 12:812. PubMed
  252. Tan L, et al. 2022. Aging Dis. 13:1562. PubMed
  253. Chen R, et al. 2022. J Mol Cell Biol. 14:. PubMed
  254. Cheng C, et al. 2022. Cell Mol Gastroenterol Hepatol. 15:261. PubMed
  255. Pan Y, et al. 2023. Adv Sci (Weinh). 10:e2206792. PubMed
  256. Wang X, et al. 2023. J Immunother Cancer. 11:. PubMed
  257. Lu C, et al. 2023. Antiviral Res. 212:105556. PubMed
  258. Zhuang WR, et al. 2023. Nat Commun. 14:1675. PubMed
  259. Tan X, et al. 2023. Adv Sci (Weinh). 10:e2206768. PubMed
  260. Martins Nascentes Melo L, et al. 2023. J Immunother Cancer. 11:. PubMed
  261. Li D, et al. 2023. Ann Med. 55:2189295. PubMed
  262. Zuo B, et al. 2023. Clin Transl Oncol. . PubMed
  263. Pandit M, et al. 2023. Nat Commun. 14:2593. PubMed
  264. Yu L, et al. 2023. Front Oncol. 13:1174713. PubMed
  265. Deng G, et al. 2023. Cancers (Basel). 15:. PubMed
  266. Wang Y, et al. 2023. iScience. 26:106630. PubMed
  267. Gao Y, et al. 2023. iScience. 26:106729. PubMed
  268. Vereertbrugghen A, et al. 2023. J Neuroinflammation. 20:120. PubMed
  269. Changsheng H, et al. 2023. Sci Adv. 9:eade4186. PubMed
  270. Yang QC, et al. 2023. iScience. 26:106916. PubMed
  271. Lin W, et al. 2020. Theranostics. 10:4871. PubMed
  272. Zhou J, et al. 2019. Immunity. 50:403. PubMed
  273. Shi L, et al. 2019. Theranostics. 9:4115. PubMed
  274. Alissafi T, et al. 2018. J Clin Invest. 128:3840. PubMed
  275. Gern BH, et al. 2021. Cell Host Microbe. 29(4):594-606.e6. PubMed
  276. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  277. Zhou J, et al. 2021. Int J Med Sci. 18:3516. PubMed
  278. Kim D, et al. 2021. Nanomicro Lett. 13:31. PubMed
  279. Gálvez-Cancino F, et al. 2017. Vaccine. 10.1016/j.vaccine.2017.06.041. PubMed
  280. Wang X, et al. 2018. Int Immunopharmacol. 56:249. PubMed
  281. Liu QZ, et al. 2018. Front Immunol. 1.131944444. PubMed
  282. Xia S, et al. 2014. J Leukoc Biol. 95:733. PubMed
  283. Su N, Xiong Y 2016. Sci Rep. 6:22658. PubMed
  284. Dong L, et al. 2021. Cancer Cell. . PubMed
  285. Yang F, et al. 2021. Front Microbiol. 11:512581. PubMed
  286. Kiritsy MC, et al. 2021. Elife. 10:. PubMed
  287. Stegelmeier AA, et al. 2022. Biomedicines. 10:. PubMed
  288. Chen L, et al. 2022. Mol Ther Oncolytics. 24:522. PubMed
  289. Liang S, et al. 2022. Acta Pharm Sin B. 12:2494. PubMed
  290. Coleby R, et al. 2021. Clin Exp Rheumatol. :39. PubMed
  291. Zhang S, et al. 2022. Cell Death Dis. 13:844. PubMed
  292. Chakrabarti J, et al. 2018. Oncotarget. 9:37439. PubMed
  293. Oyarce C, et al. 2018. Front Immunol. 8:1794. PubMed
  294. Tang Y, et al. 2020. Front Immunol. 11:585918. PubMed
  295. Mayer RL, et al. 2022. Nat Commun. 13:6075. PubMed
  296. Snyder LM, et al. 2021. PLoS Pathog. 17:e1009970. PubMed
  297. Nagatake T, et al. 2022. Mucosal Immunol. 15:289. PubMed
  298. Herman JD, et al. 2021. Nat Commun. 12:6853. PubMed
  299. Galeano Niño JL, et al. 2020. J Cell Sci. . PubMed
  300. Saito S, et al. 2020. Nutrients. 12:. PubMed
  301. Chen D, et al. 2018. Nat Commun. 9:873. PubMed
  302. Koenecke C, et al. 2012. J Immunol. 189:2890. PubMed
  303. Michel M, et al. 2012. Proc Natl Acad Sci U S A. 109:17459. PubMed
  304. Wang Y, et al. 2016. Sci Rep. 6:31881. PubMed
  305. Papafragkos I, et al. 2022. Front Immunol. 13:889075. PubMed
  306. Xiong A, et al. 2022. EBioMedicine. 83:104239. PubMed
  307. Pan W et al. 2017. Immunity. 47(2):284-297 . PubMed
  308. Ning X, et al. 2019. Mol Cell. 74:19. PubMed
  309. Uchimura T et al. 2018. Immunity. 49(6):1049-1061 . PubMed
  310. Lv H, et al. 2020. Cell Metabolism. 33(1):110-127.e5. PubMed
  311. Alissafi T, et al. 2020. Cell Metabolism. 32(4):591-604.e7. PubMed
  312. Sharma S, et al. 2015. J Immunol. 194:5529. PubMed
  313. Dai B, et al. 2022. Theranostics. 12:7603. PubMed
  314. Kuttke M, et al. 2022. Front Immunol. 13:695576. PubMed
  315. Xu X, et al. 2021. J Nanobiotechnology. 19:376. PubMed
  316. Subbiah J, et al. 2022. NPJ Vaccines. 7:68. PubMed
  317. Wang C, et al. 2021. Cell Rep. 37:110021. PubMed
  318. Uchil PD et al. 2018. Cell host & microbe. 25(1):87-100 . PubMed
  319. Probst P, et al. 2017. Cancer Res. 77:3644. PubMed
  320. Caronni N, et al. 2018. Cancer Res. 78:1685. PubMed
  321. Wan Y, et al. 2014. Vaccine. 41:241. PubMed
  322. Sandrock I, et al. 2015. PLoS One. 10: 0145010. PubMed
  323. Koren N, et al. 2021. Cell Host Microbe. 29(2):197-209.e5. PubMed
  324. An J, et al. 2022. iScience. 25:103570. PubMed
  325. Han JP, et al. 2022. Sci Adv. 8:eabj6901. PubMed
  326. Yu Y, et al. 2022. Nat Commun. 13:6357. PubMed
  327. Hegde S, et al. 2020. Cancer Cell. 37(3):289-307. PubMed
  328. Shami A, et al. 2015. Sci Rep. 5: 13904. PubMed
  329. Gungor B, et al. 2014. Sci Transl Med. 6:235. PubMed
  330. Srey MT, et al. 2020. PLoS Negl Trop Dis. 14:e0008842. PubMed
  331. Chen D, et al. 2022. J Neuroinflammation. 19:112. PubMed
  332. Cha SE, et al. 2021. Oncoimmunology. 10:1899469. PubMed
  333. Canton J, et al. 2021. Nat Immunol. 22:140. PubMed
  334. Espinosa JR, et al. 2018. Front Immunol. 9:1371. PubMed
  335. Hundt M, et al. 2009. J Immunol. 183:1685. PubMed
  336. Cho K, Hill A 2008. J Immunol Methods. 330:137. PubMed
  337. Condotta S, et al. 2015. J Immunol. 195: 116 - 125. PubMed
  338. Satoh M, et al. 2016. Sci Rep. 6:28473. PubMed
  339. Gong Y, et al. 2020. Cell Metabolism. 33(1):51-64.e9. PubMed
  340. Duan RN, et al. 2021. J Neuroinflammation. 18:145. PubMed
  341. Hanasoge Somasundara AV, et al. 2021. Cell Rep. 37:110099. PubMed
  342. Cheng B, et al. 2022. Cancer Commun (Lond). 42:17. PubMed
  343. Mirando AC, et al. 2020. Oncoimmunology. 9:1760685. PubMed
  344. Garo LP, et al. 2019. Cell Rep. 28:3353. PubMed
  345. Li W, et al. 2019. Nat Commun. 10:3349. PubMed
  346. Yan Y, et al. 2018. JCI Insight. 3. PubMed
  347. Place D, et al. 2017. PLoS One. 10.1371/journal.pone.0190384. PubMed
  348. Palazon A, et al. 2017. Cancer Cell. . 10.1016/j.ccell.2017.10.003. PubMed
  349. Brigas HC, et al. 2021. Cell Reports. 36(9):109574. PubMed
  350. Sartorius R, et al. 2015. EMBO Mol Med. 7: 973 - 988. PubMed
  351. Reese B, et al. 2020. J Immunol. 205:3218. PubMed
  352. Marcus A et al. 2018. Immunity. 49(4):754-763 . PubMed
  353. Ma Y, et al. 2013. J Immunol. 190:5588. PubMed
  354. Dutow P, et al. 2014. J Infect Dis. 209:1269. PubMed
  355. QT N, et al. 2015. Antimicrob Agents Chemother. 59: 6308-6316. PubMed
  356. Latasa C, et al. 2016. PLoS One. 11: 0161216. PubMed
  357. Holokai L, et al. 2020. Cancers (Basel). 12:00. PubMed
  358. Galeano Niño JL, et al. 2020. J Cell Sci. 133:00:00. PubMed
  359. Vaena S, et al. 2021. Cell Reports. 35(5):109076. PubMed
  360. Bosnjak B, et al. 2021. Front Immunol. 12:772240. PubMed
  361. Tian X, et al. 2022. J Cell Mol Med. 26:693. PubMed
  362. Kraus Z, et al. 2008. J Immunol. 181:7800. PubMed
  363. Lin W, et al. 2019. EBioMedicine. 49:133. PubMed
  364. Leclerc M, et al. 2019. Nat Commun. 10:3345. PubMed
  365. Nagatake T, et al. 2018. Int Immunol. 30:471. PubMed
  366. Chatterjee S et al. 2017. Cell metabolism. 27(1):85-100 . PubMed
  367. Yan J, et al. 2020. Cell Rep. 107820:31. PubMed
  368. Shen JZ, et al. 2020. Cell. 184(2):352-369.e23. PubMed
  369. Ren Y, et al. 2015. Sci Rep. 5: 18099. PubMed
  370. Yang Z, et al. 2021. Onco Targets Ther. 14:4239. PubMed
  371. De Ponte Conti B, et al. 2021. Elife. 10:. PubMed
  372. Tanaka Y, et al. 2020. Sci Rep. 10:17284. PubMed
  373. Ohtsuka J, et al. 2021. iScience. Online ahead of print. PubMed
  374. Lu J, et al. 2021. Cell Death Discov. 7:165. PubMed
  375. Karandikar SH, et al. 2019. JCI Insight. 5. PubMed
  376. Bartolacci C, et al. 2018. Cancer Immunol Res. 1.281944444. PubMed
  377. Montfort M, et al. 2004. J Immunol. 173:4084. PubMed
  378. Koelwyn GJ, et al. 2020. Nat Med. 1452:26. PubMed
  379. Xu P, et al. 2020. Cancer Immunol Res. 8:1193. PubMed
  380. Xu Q, et al. 2021. Theranostics. 11:1937. PubMed
  381. Guo S, et al. 2021. Sci Rep. 11:23745. PubMed
  382. Kalafati L, et al. 2020. Cell. 183:771. PubMed
  383. Roy S, et al. 2019. Front Immunol. 2.404166667. PubMed
  384. Yuan X, et al. 2017. Elife. 6:e29540. PubMed
  385. Nagatake T, et al. 2018. J Allergy Clin Immunol. 142:470. PubMed
  386. Zhang J, et al. 2018. Nature. 553:91. PubMed
  387. Wang Y, et al. 2020. Virol Sin. 36:122. PubMed
  388. Hirata SI, et al. 2020. Allergy. 75:1939. PubMed
  389. Castiglioni P, et al. 2017. PLoS Negl Trop Dis. 10.1371/journal.pntd.0005240. PubMed
  390. Dong M, et al. 2022. J Immunother Cancer. 10:. PubMed
  391. Ye Q, et al. 2022. NPJ Vaccines. 7:84. PubMed
  392. Stephens WZ, et al. 2021. Cell Rep. 37:109916. PubMed
  393. Raju S, et al. 2020. Cell Reports. 29(9):2556-2564.e3.. PubMed
  394. Mandour MF, et al. 2020. Infect Agent Cancer. 15:30. PubMed
  395. Miura N, et al. 2017. Mol Ther. 10.1016/j.ymthe.2017.01.020. PubMed
  396. Miao W, et al. 2020. J Immunol. 1486:204. PubMed
  397. Cartwright ANR, et al. 2021. Cancer Immunol Res. 9:470. PubMed
  398. Li H, et al. 2021. Front Immunol. 12:739605. PubMed
  399. Kiritsy MC, et al. 2021. Elife. 10:. PubMed
  400. Tian D, et al. 2019. Nat Commun. 10:4246. PubMed
  401. Mah-Som AY, et al. 2021. Cell Reports. 35(9):109209. PubMed
  402. Lee J, et al. 2007. Nat Immunol. 8:181. PubMed
  403. Ma Q, et al. 2022. Vaccines (Basel). 10:. PubMed
  404. Kim MY, et al. 2022. Nat Commun. 13:3296. PubMed
  405. Johnson RM, et al. 2021. Front Immunol. 11:614697. PubMed
  406. Ding L et al. 2018. Cell reports. 25(11):2972-2980 . PubMed
  407. Tomaru U et al. 2019. Cell reports. 26(3):639-651 . PubMed
  408. Hoechst B, et al. 2016. J Immunol. 195:1517-1523. PubMed
  409. Molgora M, et al. 2020. Cell. 182:886. PubMed
  410. Fang W, et al. 2021. J Exp Clin Cancer Res. 40:4. PubMed
  411. Chen L, et al. 2021. Theranostics. 11:6668. PubMed
  412. Rousso-Noori L, et al. 2021. Nat Commun. 12:3615. PubMed
  413. Wang Y, et al. 2021. Front Immunol. 11:601601. PubMed
  414. Prakash MD, et al. 2021. PLoS One. 16:e0247492. PubMed
  415. Zhang X, et al. 2020. J Cancer. 11:648. PubMed
  416. Chakraborty P, et al. 2020. Cell Reports. 28(7):1879-1893.e7.. PubMed
  417. Zhao K, et al. 2021. Biomed Res Int. 7619849:2020. PubMed
  418. Charlton J, et al. 2015. PLoS One. 10:119200. PubMed
  419. Nakao R, et al. 2022. NPJ Vaccines. 7:153. PubMed
  420. McAusland TM, et al. 2021. Mol Ther Oncolytics. 20:306. PubMed
  421. Li H, et al. 2022. iScience. 25:104481. PubMed
  422. Schmit T, et al. 2022. Cell Rep. 38:110456. PubMed
  423. Zhang X, et al. 2021. Front Pharmacol. 12:706748. PubMed
  424. Liu X, et al. 2021. Adv Sci (Weinh). 8:e2100233. PubMed
  425. Timilshina M, et al. 2020. Cell Reports. 27(10):2948-2961.e7.. PubMed
  426. Kim YS, et al. 2018. Front Immunol. 9:1093. PubMed
  427. Wang N, et al. 2020. Front Immunol. 1.765972222. PubMed
  428. Gaylo A, et al. 2013. Transpl Immunol. 20:163. PubMed
  429. Dourcy M, et al. 2020. Mucosal Immunol. 13:799. PubMed
  430. Kerdidani D, et al. 2022. J Exp Med. 219:. PubMed
  431. Zheng Y, et al. 2022. Transl Res. :. PubMed
  432. Brenner E, et al. 2020. Nat Commun. 11:1335. PubMed
  433. Qi S, et al. 2020. Theranostics. 10:1814. PubMed
  434. Chen S, et al. 2018. Nat Commun. 9:5298. PubMed
  435. Bing Wu et al. 2018. Immunity. 49(5):886-898 . PubMed
  436. Nabekura T, et al. 2020. Immunity. 96:52. PubMed
  437. Chow AK, et al. 2021. Cellular and Molecular Gastroenterology and Hepatology. :. PubMed
  438. Tripathi D, et al. 2016. Nat Commun. 7:13896. PubMed
  439. Chen PM, et al. 2022. Sci Adv. 8:eabo4271. PubMed
  440. Song X, et al. 2022. Transl Oncol. 15:101306. PubMed
  441. Yang F, et al. 2021. Nat Commun. 12:3424. PubMed
  442. Li X, et al. 2021. Front Cell Dev Biol. 9:647713. PubMed
RRID
AB_315401 (BioLegend Cat. No. 505807)
AB_315402 (BioLegend Cat. No. 505808)

Antigen Details

Structure
Cytokine; dimer; 40-80 kD (Mammalian)
Bioactivity
Antiviral/antiparasitic activities; inhibits proliferation; enhances MHC class I and II expression on APCs
Cell Sources
CD8+ and CD4+ T cells, NK cells
Cell Targets
T cells, B cells, macrophages, NK cells, endothelial cells, fibroblasts
Receptors
IFN-γRα (CDw119) dimerized with IFN-γRβ (AF-1)
Cell Type
Tregs
Biology Area
Cell Biology, Immunology, Neuroinflammation, Neuroscience
Molecular Family
Cytokines/Chemokines
Antigen References

1. Fitzgerald K, et al. Eds. 2001. The Cytokine FactsBook. Academic Press, San Diego.
2. De Maeyer E, et al. 1992. Curr. Opin. Immunol. 4:321.
3. Farrar M, et al. 1993. Annu. Rev. Immunol. 11:571.
4. Gray P, et al. 1987. Lymphokines 13:151.

Regulation
Upregulated by IL-2, FGF-basic, EGF; downregulated by 1-α-25-Dihydroxy vitamin D3, dexamethasone
Gene ID
15978 View all products for this Gene ID
UniProt
View information about IFN-gamma on UniProt.org

Related FAQs

What type of PE do you use in your conjugates?
We use R-PE in our conjugates.

Other Formats

View All IFN-γ Reagents Request Custom Conjugation
Description Clone Applications
Alexa Fluor® 700 anti-mouse IFN-γ XMG1.2 ICFC
APC/Cyanine7 anti-mouse IFN-γ XMG1.2 ICFC
GoInVivo™ Purified anti-mouse IFN-γ XMG1.2 ELISA Capture,ELISPOT Capture,CyTOF®,Neut,ICFC,IHC,WB
APC/Fire™ 750 anti-mouse IFN-γ XMG1.2 ICFC
APC anti-mouse IFN-γ XMG1.2 ICFC
Biotin anti-mouse IFN-γ XMG1.2 ELISA Detection,ELISPOT Detection,ICFC
FITC anti-mouse IFN-γ XMG1.2 ICFC
PE anti-mouse IFN-γ XMG1.2 ICFC
Purified anti-mouse IFN-γ XMG1.2 ELISA Capture,CyTOF®,IHC,WB
Alexa Fluor® 488 anti-mouse IFN-γ XMG1.2 ICFC
Alexa Fluor® 647 anti-mouse IFN-γ XMG1.2 ICFC
Pacific Blue™ anti-mouse IFN-γ XMG1.2 ICFC
PerCP/Cyanine5.5 anti-mouse IFN-γ XMG1.2 ICFC
PE/Cyanine7 anti-mouse IFN-γ XMG1.2 ICFC
Brilliant Violet 421™ anti-mouse IFN-γ XMG1.2 ICFC
Brilliant Violet 650™ anti-mouse IFN-γ XMG1.2 ICFC
Ultra-LEAF™ Purified anti-mouse IFN-γ XMG1.2 ELISA Capture,ELISPOT Capture,CyTOF®,Neut,ICFC,IHC,WB
Brilliant Violet 711™ anti-mouse IFN-γ XMG1.2 ICFC
Brilliant Violet 785™ anti-mouse IFN-γ XMG1.2 ICFC
Brilliant Violet 605™ anti-mouse IFN-γ XMG1.2 ICFC
Brilliant Violet 510™ anti-mouse IFN-γ XMG1.2 ICFC
Purified anti-mouse IFN-γ (Maxpar® Ready) XMG1.2 ELISA Capture,CyTOF®
PE/Dazzle™ 594 anti-mouse IFN-γ XMG1.2 ICFC
Spark NIR™ 685 anti-mouse IFN-γ XMG1.2 ICFC
Spark UV™ 387 anti-mouse IFN-γ XMG1.2 ICFC
Brilliant Violet 750™ anti-mouse IFN-γ XMG1.2 ICFC
TotalSeq™-C1526 anti-mouse IFN-γ Antibody XMG1.2 ICPG
Go To Top Version: 2    Revision Date: 12.11.2012

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account